Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring

Hypertension is associated with structural and functional changes in blood vessels with increased arteriosclerosis, vascular inflammation, and endothelial dysfunction. Decreased adherence (compliance) to antihypertensive medications contributes significantly to morbidity and mortality in hypertensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Mobed, Ahmad, Gholami, Sarah, Tahavvori, Amir, Ghazi, Farhood, Masoumi, Zahra, Alipourfard, Iraj, Naderian, Ramtin, Mohammadzadeh, Mehran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558620/
https://www.ncbi.nlm.nih.gov/pubmed/37810167
http://dx.doi.org/10.1016/j.heliyon.2023.e19467
_version_ 1785117318182862848
author Mobed, Ahmad
Gholami, Sarah
Tahavvori, Amir
Ghazi, Farhood
Masoumi, Zahra
Alipourfard, Iraj
Naderian, Ramtin
Mohammadzadeh, Mehran
author_facet Mobed, Ahmad
Gholami, Sarah
Tahavvori, Amir
Ghazi, Farhood
Masoumi, Zahra
Alipourfard, Iraj
Naderian, Ramtin
Mohammadzadeh, Mehran
author_sort Mobed, Ahmad
collection PubMed
description Hypertension is associated with structural and functional changes in blood vessels with increased arteriosclerosis, vascular inflammation, and endothelial dysfunction. Decreased adherence (compliance) to antihypertensive medications contributes significantly to morbidity and mortality in hypertensive patients. Antihypertensive drugs (AHTDs) and lifestyle changes are the main cornerstones for treating hypertension. Several approaches have been described in the literature for determining AHTDs based on different analytical techniques. Amongst biosensors are one of the most attractive tools due to their inherent advantages. Biosensors are used for the detection of wide range of biomarkers as well as different drugs in past two decades. The main focus of the present study is to review the latest biosensors developed for the detection of AHTDs. Readers of the present study will be able to familiarize themselves with biosensors as advanced and modern diagnostic tools while reviewing the most widely used AHTDs. In the present study, the routine methods are first reviewed and while examining their advantages and disadvantages, biosensors have been introduced as ideal alternative tools.
format Online
Article
Text
id pubmed-10558620
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105586202023-10-08 Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring Mobed, Ahmad Gholami, Sarah Tahavvori, Amir Ghazi, Farhood Masoumi, Zahra Alipourfard, Iraj Naderian, Ramtin Mohammadzadeh, Mehran Heliyon Review Article Hypertension is associated with structural and functional changes in blood vessels with increased arteriosclerosis, vascular inflammation, and endothelial dysfunction. Decreased adherence (compliance) to antihypertensive medications contributes significantly to morbidity and mortality in hypertensive patients. Antihypertensive drugs (AHTDs) and lifestyle changes are the main cornerstones for treating hypertension. Several approaches have been described in the literature for determining AHTDs based on different analytical techniques. Amongst biosensors are one of the most attractive tools due to their inherent advantages. Biosensors are used for the detection of wide range of biomarkers as well as different drugs in past two decades. The main focus of the present study is to review the latest biosensors developed for the detection of AHTDs. Readers of the present study will be able to familiarize themselves with biosensors as advanced and modern diagnostic tools while reviewing the most widely used AHTDs. In the present study, the routine methods are first reviewed and while examining their advantages and disadvantages, biosensors have been introduced as ideal alternative tools. Elsevier 2023-08-27 /pmc/articles/PMC10558620/ /pubmed/37810167 http://dx.doi.org/10.1016/j.heliyon.2023.e19467 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Mobed, Ahmad
Gholami, Sarah
Tahavvori, Amir
Ghazi, Farhood
Masoumi, Zahra
Alipourfard, Iraj
Naderian, Ramtin
Mohammadzadeh, Mehran
Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring
title Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring
title_full Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring
title_fullStr Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring
title_full_unstemmed Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring
title_short Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring
title_sort nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558620/
https://www.ncbi.nlm.nih.gov/pubmed/37810167
http://dx.doi.org/10.1016/j.heliyon.2023.e19467
work_keys_str_mv AT mobedahmad nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring
AT gholamisarah nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring
AT tahavvoriamir nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring
AT ghazifarhood nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring
AT masoumizahra nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring
AT alipourfardiraj nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring
AT naderianramtin nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring
AT mohammadzadehmehran nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring